Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
A. Senthilkumar & V. Venkatesalu. (2013)
In vitro fungitoxic and cytotoxic efficacy of Chloroxylon swietenia DC. leaf essential oil. Journal of Essential Oil Research 25:4, pages 348-353.
Read now
Read now
Mohd Sajjad Ahmad Khan, Abida Malik & Iqbal Ahmad. (2012) Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans. Medical Mycology 50:1, pages 33-42.
Read now
Read now
Athanasios Desalermos, Maged Muhammed, Justin Glavis-Bloom & Eleftherios Mylonakis. (2011) Using Caenorhabditis elegans for antimicrobial drug discovery. Expert Opinion on Drug Discovery 6:6, pages 645-652.
Read now
Read now
Douglas S Kwon & Eleftherios Mylonakis. (2007) Posaconazole: a new broad-spectrum antifungal agent. Expert Opinion on Pharmacotherapy 8:8, pages 1167-1178.
Read now
Read now
Articles from other publishers (40)
Emeka Ugoala. (2023) Antibacterial Resistant Pathogens Potential Reservoirs. Current Research in Bacteriology 16:1, pages 1-16.
Crossref
Crossref
Reza Ghasemi, Ensieh Lotfali, Kamran Rezaei, Seyed Ataollah Madinehzad, Mahdi Falah Tafti, Nikta Aliabadi, Ebrahim Kouhsari & Mahsa Fattahi. (2022) Meyerozyma guilliermondii species complex: review of current epidemiology, antifungal resistance, and mechanisms. Brazilian Journal of Microbiology 53:4, pages 1761-1779.
Crossref
Crossref
Anh Dao Thi Phan, Mridusmita Chaliha, Yasmina Sultanbawa & Michael E. Netzel. (2019) Nutritional Characteristics and Antimicrobial Activity of Australian Grown Feijoa (Acca sellowiana). Foods 8:9, pages 376.
Crossref
Crossref
Juliana Giacobino, Augusto Cezar Montelli, Pasqual Barretti, Ariane Bruder-Nascimento, Jacqueline Teixeira Caramori, Luciano Barbosa & Eduardo Bagagli. (2016) Fungal peritonitis in patients undergoing peritoneal dialysis (PD) in Brazil: molecular identification, biofilm production and antifungal susceptibility of the agents. Medical Mycology 54:7, pages 725-732.
Crossref
Crossref
Hemanth Noothalapati, Takahiro Sasaki, Tomohiro Kaino, Makoto Kawamukai, Masahiro Ando, Hiro-o Hamaguchi & Tatsuyuki Yamamoto. (2016) Label-free Chemical Imaging of Fungal Spore Walls by Raman Microscopy and Multivariate Curve Resolution Analysis. Scientific Reports 6:1.
Crossref
Crossref
Takao Watamoto, Hiroshi Egusa, Takashi Sawase & Hirofumi Yatani. (2015) Screening of Pharmacologically Active Small Molecule Compounds Identifies Antifungal Agents Against Candida Biofilms. Frontiers in Microbiology 6.
Crossref
Crossref
Thomas J. Walsh, Nkechi Azie & David R. Andes. (2015) Development of New Strategies for Echinocandins: Progress in Translational Research. Clinical Infectious Diseases 61:suppl_6, pages S601-S603.
Crossref
Crossref
Guilherme R Teodoro, Fernanda L Brighenti, Alberto C Botazzo Delbem, Ádina Cléia B Delbem, Sonia Khouri, Aline Vidal L Gontijo, Aislan CRF Pascoal, Marcos J Salvador & Cristiane Y Koga-Ito. (2015)
Antifungal activity of extracts and isolated compounds from
Buchenavia tomentosa
on
Candida albicans
and non-
albicans
. Future Microbiology 10:6, pages 917-927.
Crossref
Crossref
Anne Tøndervik, Håvard Sletta, Geir Klinkenberg, Charlotte Emanuel, Lydia C. Powell, Manon F. Pritchard, Saira Khan, Kieron M. Craine, Edvar Onsøyen, Phil D. Rye, Chris Wright, David W. Thomas & Katja E. Hill. (2014) Alginate Oligosaccharides Inhibit Fungal Cell Growth and Potentiate the Activity of Antifungals against Candida and Aspergillus spp. PLoS ONE 9:11, pages e112518.
Crossref
Crossref
Potikuri Damodaram, Adapa Ramakrishnam Naidu, Kanchinadam Suresh, Liza Rajasekhar & Gumdal Narsimulu. (2012) Lupus‐like presentation and rare dual infections in an immunocompetent individual. International Journal of Rheumatic Diseases 15:3.
Crossref
Crossref
Nasrullah A. Undre, Paul Stevenson, Ernst-Rüdiger Kuse & Ignace Demeyer. (2012) Pharmacokinetics of Micafungin in Adult Patients with Invasive Candidiasis and Candidemia. Open Journal of Medical Microbiology 02:03, pages 84-90.
Crossref
Crossref
Herman Anthony Carneiro, Anastasios Mavrakis & Eleftherios Mylonakis. (2011) Candida Peritonitis: An Update on the Latest Research and Treatments. World Journal of Surgery 35:12, pages 2650-2659.
Crossref
Crossref
Jennifer F. Ha, Claire M. Italiano, Christopher H. Heath, Sophia Shih, Suzanne Rea & Fiona M. Wood. (2011) Candidemia and invasive candidiasis: A review of the literature for the burns surgeon. Burns 37:2, pages 181-195.
Crossref
Crossref
Miguel Montejo & Guillermo Quindós. (2011) Evidencias científicas que respaldan el uso de micafungina en el tratamiento de la candidiasis invasora. Enfermedades Infecciosas y Microbiología Clínica 29, pages 15-22.
Crossref
Crossref
Terry Roemer, Deming Xu, Sheo B. Singh, Craig A. Parish, Guy Harris, Hao Wang, Julian E. Davies & Gerald F. Bills. (2011) Confronting the Challenges of Natural Product-Based Antifungal Discovery. Chemistry & Biology 18:2, pages 148-164.
Crossref
Crossref
Hui LU, Ying-ying CAO, Yan WANG, Ping-hui GAO, Yong-bing CAO & Yuan-ying JIANG. (2010) Green fluorescent protein in <I>Candida albicans</I>-related studies. Academic Journal of Second Military Medical University 30:5, pages 541-544.
Crossref
Crossref
Donald J. AbrahamDavid J. Newman & Gordon M. Cragg. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
221
258
.
David J. Newman & Gordon M. Cragg. 2010. Comprehensive Natural Products II. Comprehensive Natural Products II
623
650
.
Fabrizio Manetti, Daniele Castagnolo, Francesco Raffi, Alessandra T. Zizzari, Suvi Rajamäki, Silvia D’Arezzo, Paolo Visca, Alessandra Cona, Maria Enrica Fracasso, Denise Doria, Brunella Posteraro, Maurizio Sanguinetti, Giovanni Fadda & Maurizio Botta. (2009)
Synthesis of New Linear Guanidines and Macrocyclic Amidinourea Derivatives Endowed with High Antifungal Activity against
Candida
spp. and
Aspergillus
spp.
. Journal of Medicinal Chemistry 52:23, pages 7376-7379.
Crossref
Crossref
David J. Newman & Gordon M. Cragg. 2009. Natural Product Chemistry for Drug Discovery. Natural Product Chemistry for Drug Discovery
3
27
.
T. Watamoto, L.P. Samaranayake, J.A.M.S. Jayatilake, H. Egusa, H. Yatani & C.J. Seneviratne. (2009) Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans. International Journal of Antimicrobial Agents 34:4, pages 333-339.
Crossref
Crossref
L.A. Braga-Silva, D.G.A. Mesquita, M.D. Ribeiro, S.M.F. Carvalho, S.E.L. Fracalanzza & A.L.S. Santos. (2009) Trailing end-point phenotype antibiotic-sensitive strains of Candida albicans produce different amounts of aspartyl peptidases. Brazilian Journal of Medical and Biological Research 42:8, pages 765-770.
Crossref
Crossref
Guillermo Quindós, Elena Eraso, Alfonso Javier Carrillo-Muñoz, Emilia Cantón & Javier Pemán. (2009) Actividad antifúngica in vitro de la micafungina. Revista Iberoamericana de Micología 26:1, pages 35-41.
Crossref
Crossref
Anders M. Näär & Jitendra K. Thakur. (2009) Nuclear receptor-like transcription factors in fungi. Genes & Development 23:4, pages 419-432.
Crossref
Crossref
Delphine Kerob, Martine Feuillhade-de-Chauvin & Celeste Lebbe. 2009. Life-Threatening Dermatoses and Emergencies in Dermatology. Life-Threatening Dermatoses and Emergencies in Dermatology
133
143
.
Gloria Mattiuzzi & Luis Ostrosky-Zeichner. 2010. Managing Infections in Patients With Hematological Malignancies. Managing Infections in Patients With Hematological Malignancies
113
134
.
Gregory C. Adam, Craig A. Parish, Douglas Wisniewski, Juncai Meng, Min Liu, Kathleen Calati, Benjamin D. Stein, John Athanasopoulos, Paul Liberator, Terry Roemer, Guy Harris & Kevin T. Chapman. (2008) Application of Affinity Selection/Mass Spectrometry to Determine the Structural Isomer of Parnafungins Responsible for Binding Polyadenosine Polymerase. Journal of the American Chemical Society 130:49, pages 16704-16710.
Crossref
Crossref
Eike Hollenbach. (2008) Invasive candidiasis in the ICU: evidence based and on the edge of evidence. Mycoses 51, pages 25-45.
Crossref
Crossref
C. I. Montero, Y. R. Shea, P. A. Jones, S. M. Harrington, N. E. Tooke, F. G. Witebsky & P. R. Murray. (2008) Evaluation of Pyrosequencing® technology for the identification of clinically relevant non-dematiaceous yeasts and related species. European Journal of Clinical Microbiology & Infectious Diseases 27:9, pages 821-830.
Crossref
Crossref
Heather M. Starmer, Donna C. Tippett & Kimberly T. Webster. (2008) Effects of Laryngeal Cancer on Voice and Swallowing. Otolaryngologic Clinics of North America 41:4, pages 793-818.
Crossref
Crossref
H. Hof. (2008) Developments in the epidemiolgy of invasive fungal infections – implications for the empiric and targeted antifungal therapy. Mycoses 51:s1, pages 1-6.
Crossref
Crossref
Bobby L. Boyanton, Jr, Ruth Ann Luna, Lea R. Fasciano, Kyle G. Menne & James Versalovic. (2008)
DNA Pyrosequencing–Based Identification of Pathogenic
Candida
Species by Using the Internal Transcribed Spacer 2 Region
. Archives of Pathology & Laboratory Medicine 132:4, pages 667-674.
Crossref
Crossref
Jitendra K. Thakur, Haribabu Arthanari, Fajun Yang, Shih-Jung Pan, Xiaochun Fan, Julia Breger, Dominique P. Frueh, Kailash Gulshan, Darrick K. Li, Eleftherios Mylonakis, Kevin Struhl, W. Scott Moye-Rowley, Brendan P. Cormack, Gerhard Wagner & Anders M. Näär. (2008) A nuclear receptor-like pathway regulating multidrug resistance in fungi. Nature 452:7187, pages 604-609.
Crossref
Crossref
. 2008. Innere Medizin. Innere Medizin
571
745
.
Mark S. Butler & David J. Newman. 2008. Natural Compounds as Drugs Volume I. Natural Compounds as Drugs Volume I
1
44
.
Lys Adriana Braga-Silva, André Luis Souza dos Santos, Maristela Barbosa Portela, Thaïs Souto-Padrón & Rosangela Maria de Araújo Soares. (2007)
Effect of suramin on the human pathogen
Candida albicans
: implications on the fungal development and virulence
. FEMS Immunology & Medical Microbiology 51:2, pages 399-406.
Crossref
Crossref
Neeraj Chauhan, Michael Kruppa & Richard Calderone. (2007)
The Ssk1p Response Regulator and Chk1p Histidine Kinase Mutants of
Candida albicans
Are Hypersensitive to Fluconazole and Voriconazole
. Antimicrobial Agents and Chemotherapy 51:10, pages 3747-3751.
Crossref
Crossref
Michael Weig & Alistair J.P. Brown. (2007) Genomics and the development of new diagnostics and anti-Candida drugs. Trends in Microbiology 15:7, pages 310-317.
Crossref
Crossref
R. O. S. Fontenelle, S. M. Morais, E. H. S. Brito, M. R. Kerntopf, R. S. N. Brilhante, R. A. Cordeiro, A. R. Tomé, M. G. R. Queiroz, N. R. F. Nascimento, J. J. C. Sidrim & M. F. G. Rocha. (2007) Chemical composition, toxicological aspects and antifungal activity of essential oil from Lippia sidoides Cham.. Journal of Antimicrobial Chemotherapy 59:5, pages 934-940.
Crossref
Crossref
Donna MacCallum. 2007. New Insights in Medical Mycology. New Insights in Medical Mycology
99
129
.